Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004745 | 1.00 | PRKCA (0.53) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9054604 | 0.92 | PRKCA (0.50) | PRKCAMAPTKMT2ALMNADUSP3 | |
| SCHEMBL9055070 | 0.92 | PRKCA (0.50) | PRKCAMAPTKMT2ALMNADUSP3 | |
| SCHEMBL4964792 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9055293 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9055938 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL1666730 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9057567 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL6252306 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL8369299 | 0.88 | PRKCA (0.54) | PRKCADGKAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452482-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | Neurotrope Bioscience, Inc. (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2018187647-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISEASES, DISORDERS, OR CONDITIONS | NEUROTROPE BIOSCIENCE, INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2017192906-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | NEUROTROPE BIOSCIENCE, INC. (US) | 2017-11-09 | — | — | WO | claimed |
| EP-3065732-A1 | COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA | Centre National de la Recherche Scientifique (CNRS) (FR) | 2016-09-14 | — | — | EP | claimed |
| WO-2015052237-A1 | COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-04-16 | — | — | WO | claimed |
| WO-2012012498-A9 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2012-04-05 | — | — | WO | claimed |
| WO-2012012498-A2 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2012-01-26 | — | — | WO | claimed |
| WO-2003040354-A1 | CAPACITATIVE CALCIUM ENTRY MECHANISM IN PORCINE OOCYTES | ALEXION PHARMACEUTICALS, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| WO-2023122772-A1 | OXIME DERIVATIVES USEFUL AS T CELL ACTIVATORS | GOSSAMER BIO SERVICES, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2022204377-A1 | NOVEL CHEMICAL COMBINATIONS AND METHODS OF USE THEREOF, TOWARDS DIFFERENTIATION OF HUMAN PROGENITOR CELLS INTO FUNCTIONAL β CELLS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2022-09-29 | — | — | WO | disclosed |
| WO-2021035037-A1 | METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCK | GEORGETOWN UNIVERSITY (US) | 2021-02-25 | — | — | WO | disclosed |
| EP-3752503-A1 | INHIBITORS OF TRPC6 | Boehringer Ingelheim International GmbH (DE) | 2020-12-23 | — | — | EP | disclosed |
| WO-2019161010-A1 | INHIBITORS OF TRPC6 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2019-08-22 | — | — | WO | disclosed |
| EP-3452482-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | Neurotrope Bioscience, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| WO-1998007438-A1 | COMPOSITIONS AND METHODS FOR SKIN TANNING AND PROTECTION | SKIN BIOLOGY, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1998001461-A1 | DIGLYCERID AND STEROL BASED ORGANOMETALLIC COMPLEXES AND PHARMACEUTICAL COMPOSITIONS AND DIETETIC PRODUCTS CONTAINING THEM | MAUREL SANTE (FR) | 1998-01-15 | — | — | WO | disclosed |
| EP-0815257-A1 | A METHOD OF DETECTING BIOLOGICALLY ACTIVE SUBSTANCES | NOVO NORDISK A/S (DK) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996039517-A1 | THE ERF GENETIC LOCUS AND ITS PRODUCTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996023898-A1 | A METHOD OF DETECTING BIOLOGICALLY ACTIVE SUBSTANCES | NOVO NORDISK A/S (DK) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996009810-A1 | METHODS FOR ENHANCING MELANIN SYNTHESIS IN MELANOCYTES USING DIACYLGLYCEROLS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-04-04 | — | — | WO | disclosed |